Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New diabetes drug combo aims to tame blood sugar

NCT ID NCT07239440

First seen Nov 20, 2025 · Last updated May 23, 2026 · Updated 24 times

Summary

This study tests whether adding a new drug called DA-2811 to standard diabetes medications helps people with type 2 diabetes who still have high blood sugar. About 288 adults will be randomly assigned to receive either DA-2811 or a placebo, and researchers will measure changes in blood sugar levels over time. The goal is to see if the new combination is safe and more effective at controlling diabetes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Samsung Medical Center

    Seoul, South Korea

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.